Role of Wnt canonical pathway in hematological malignancies

Journal of Hematology and Oncology

Volumn 3, Issue , 2010, Pages

  Ge, Xueling ^a   Wang, Xin ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; CYCLIN D1; DICKKOPF 1 PROTEIN; FRIZZLED PROTEIN; MATRILYSIN; NONSTEROID ANTIINFLAMMATORY AGENT; QUERCETIN; VASCULOTROPIN A; WNT PROTEIN; WNT10B PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; WNT7A PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; APOPTOSIS; BONE METASTASIS; BURKITT LYMPHOMA; CANCER GROWTH; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; COLON POLYPOSIS; COLORECTAL CANCER; EMBRYO DEVELOPMENT; EPSTEIN BARR VIRUS; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MANTLE CELL LYMPHOMA; MELANOMA; MULTIPLE MYELOMA; NEPHROBLASTOMA; NONHUMAN; ONCOGENE C MYC; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BLOOD DISEASE; PHYSIOLOGY;

ANIMALS; BETA CATENIN; HEMATOLOGIC NEOPLASMS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77956556489     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-3-33     Document Type: Review

References (65)

1. Diversification of the Wnt gene family on the ancestral lineage of vertebrates. A Sidow, Proc Natl Acad Sci USA 1992 89 5098 5102 10.1073/pnas.89.11.5098 1534411
2. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. B Rubinfeld I Albert E Porfiri C Fiol S Munemitsu P Polakis, Science 1996 272 1023 1026 10.1126/science.272.5264.1023 8638126
3. Beta-catenin as oncogene: The smoking gun. M Peifer, Science 1997 275 1752 1753 10.1126/science.275.5307.1752 9122680
4. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. PJ Morin AB Sparks V Korinek N Barker H Clevers B Vogelstein KW Kinzler, Science 1997 275 1787 1790 10.1126/science.275.5307.1787 9065402
5. Stabilization of beta-catenin by genetic defects in melanoma cell lines. B Rubinfeld P Robbins M El-Gamil I Albert E Porfiri P Polakis, Science 1997 275 1752 1753 10.1126/science.275.5307.1790 9122680
6. Detection and analysis of beta-catenin mutations in prostate cancer. DR Chesire CM Ewing J Sauvageot GS Bova WB Isaacs, Prostate 2000 45 323 334 10.1002/1097-0045(20001201)45:4<323::AID-PROS73.0.CO;2-W 11102958
7. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. A de la Taille MA Rubin MW Chen F Vacherot SG de Medina M Burchardt R Buttyan D Chopin, Clin Cancer Res 2003 9 1801 1807 12738737
8. Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. K Jeays-Ward C Hoyle J Brennan M Dandonneau G Alldus B Capel A Swain, Development 2003 130 3663 3670 10.1242/dev.00591 12835383
9. Diverse mechanisms of betacatenin deregulation in ovarian endometrioid adenocarcinomas. R Wu Y Zhai ER Fearon KR Cho, Cancer Res 2001 61 8247 8255 11719457
10. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta. K Rask A Nilsson M Brannstrom P Carlsson P Hellberg PO Janson L Hedin K Sundfeldt, Br J Cancer 2003 89 1298 1304 10.1038/sj.bjc.6601265 14520463
11. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. CL Huang D Liu S Ishikawa T Nakashima N Nakashima H Yokomise K Kadota M Ueno, EUROPEAN JOURNAL OF CANCER 2008 44 2680 2688 10.1016/j.ejca.2008.08.004 18790633
12. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. A de La Coste B Romagnolo P Billuart CA Renard MA Buendia O Soubrane M Fabre J Chelly C Beldjord A Kahn C Perret, Proc Natl Acad Sci USA 1998 95 8847 8851 10.1073/pnas.95.15.8847 9671767
13. Frequent association of beta-catenin and WT1 mutations in Wilms tumors. S Maiti R Alam CI Amos V Huff, Cancer Res 2000 60 6288 6292 11103785
14. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. J Behrens BA Jerchow M Würtele J Grimm C Asbrand R Wirtz M Kühl D Wedlich W Birchmeier, Science 1998 280 596 599 10.1126/science.280.5363.596 9554852
15. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. J Mazieres B He L You Z Xu AY Lee I Mikami N Reguart R Rosell F McCormick DM Jablons, Cancer Res 2004 64 4717 4720 10.1158/0008-5472.CAN-04-1389 15256437 (Pubitemid 38924512)
16. Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A. CL Bos LL Kodach GR van den Brink SH Diks MM van Santen DJ Richel MP Peppelenbosch JC Hardwick, Oncogene 2006 25 6447 6456 10.1038/sj.onc.1209658 16878161
17. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. N Nath K Kashfi J Chen B Rigas, Proc Natl Acad Sci USA 2003 100 12584 12589 10.1073/pnas.2134840100 14566053
18. Quercetin, a potent inhibitor against -catenin/Tcf signaling in SW480 colon cancer cells. Chi Hoon Park Joon Young Chang Eun Ryeong Hahm Seyeon Park Hyun-Kyung Kim Chul Hak Yang, Biochemical and Biophysical Research Communications 2005 328 227 234 10.1016/j.bbrc.2004.12.151 15670774
19. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. M Lepourcelet YN Chen DS France H Wang P Crews F Petersen C Bruseo AW Wood RA Shivdasani, Cancer Cell 2004 5 91 102 10.1016/S1535-6108(03)00334-9 14749129
20. ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription. M Eguchi C Nguyen SC Lee M Kahn, Med Chem 2005 1 467 472 10.2174/1573406054864098 16787331
21. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. B He N Reguart L You J Mazieres Z Xu AY Lee I Mikami F McCormick DM Jablons, Oncogene 2005 24 3054 3058 10.1038/sj.onc.1208511 15735684
22. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. L You B He Z Xu K Uematsu J Mazieres N Fujii I Mikami N Reguart JK McIntosh M Kashani-Sabet F McCormick DM Jablons, Cancer Res 2004 64 5385 5389 10.1158/0008-5472.CAN-04-1227 15289346
23. Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. M Wright M Aikawa W Szeto J Papkoff, Biochem Biophys Res Commun 1999 263 384 388 10.1006/bbrc.1999.1344 10491302
24. Targeted disruption of the Wnt2 gene results in placentation defects. SJ Monkley SJ Delaney DJ Pennisi JH Christiansen BJ Wainwright, Development 1996 122 3343 3353 8951051
25. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. T Ishikawa Y Tamai AM Zorn H Yoshida MF Seldin S Nishikawa MM Taketo, Development 2001 128 25 33 11092808
26. Differential expression of rat frizzled-related frzb-1 and frizzled receptor fz1 and fz2 genes in the rat aorta after balloon injury. C Mao OT Malek ME Pueyo PG Steg F Soubrier, Arterioscler Thromb Vasc Biol 2000 20 43 51 10634799
27. Identification, gene structure, and expression of human frizzled-3 (FZD3). CF Sala E Formenti GC Terstappen A Caricasole, Biochem Biophys Res Commun 2000 273 27 34 10.1006/bbrc.2000.2882 10873558
28. Wnt signaling in human development: Beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. CG Eberhart P Argani, Pediatr Dev Pathol 2001 4 351 357 10.1007/s10024001-0037-y 11441336
29. Wnt/-catenin signaling induces proliferation, survival and Interleukin-8 in human endothelial cells. T Ne'stor H Masckaucha'n Carrie J Shawber Yasuhiro Funahashi Chi-Ming Li Jan Kitajewski, Angiogenesis 2005 8 43 51 10.1007/s10456-005-5612-9 16132617
30. Immunohistochemical analysis of beta-catenin in N-ethyl-N-nitrosourea- induced rat gliomas: Implications in regulation ofangiogenesis. H Yano A Hara J Shinoda K Takenaka N Yoshimi H Mori N Sakai, Neurol Res 2000 22 527 532 10935229
31. Nuclear localization and mutation of beta-catenin in medulloblastomas. CG Eberhart T Tihan PC Burger, J Neuropathol Exp Neurol 2000 59 333 337 10759189
32. Differential expression of beta-catenin in human glioblastoma multiforme and normal brain tissue. H Yano A Hara K Takenaka J Shinoda K Shimokawa N Yoshimi H Mori N Sakai, Neurol Res 2000 22 650 656 11091968
33. Clinical application of biological markers for treatments of resectable non-small-cell lung cancers. C Huang D Liu D Masuya T Nakashima K Kameyama S Ishikawa M Ueno R Haba H Yokomise, Br J Cancer 2005 92 1231 1239 10.1038/sj.bjc.6602481 15785747
34. Microvessel Density and Expression of Vascular Endothelial Growth Factor and Its Receptors in Diffuse Large B-Cell Lymphoma Subtypes. D Gratzinger S Zhao RJ Marinelli AV Kapp RJ Tibshirani AS Hammer S Hamilton-Dutoit Y Natkunam, The American Journal of Pathology 2007 170 1362 1369 10.2353/ajpath.2007.060901 17392174
35. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. X Zhang JP Gaspard DC Chung, Cancer Res 2001 61 6050 6054 11507052
36. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. V Easwaran SH Lee L Inge L Guo C Goldbeck E Garrett M Wiesmann PD Garcia JH Fuller V Chan F Randazzo R Gundel RS Warren J Escobedo SL Aukerman RN Taylor WJ Fantl, Cancer Res 2003 63 3145 3153 12810642
37. Crosstalk between tumor cells and microenvironment via wnt pathway in colorectal cancer dissemination. D Huang X Du, World J Gastroenterol 2008 14 1823 1827 10.3748/wjg.14.1823 18350618
38. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. J Hu A Dong V Fernandez-Ruiz J Shan M Kawa E Martínez-Ansá J Prieto C Qian, Cancer Res 2009 69 6951 6959 10.1158/0008-5472.CAN-09-0541 19690140
39. A role for Wnt signalling in self-renewal of haematopoietic stem cells. T Reya AW Duncan L Ailles J Domen DC Scherer K Willert L Hintz R Nusse IL Weissman, Nature 2003 423 409 414 10.1038/nature01593 12717450
40. Role of Members of the Wnt Gene Family in Human Hematopoiesis. David J Van Den Berg Arun K Sharma Edward Bruno Ron Hoffman, Blood 1998 92 3189 3202 9787155
41. WNT signaling modulates the diversification of hematopoietic cells. C Brandon LM Eisenberg CA Eisenberg, Blood 2000 96 4132 4141 11110684
42. Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. TC Luis F Weerkamp BA Naber MR Baert EF de Haas T Nikolic S Heuvelmans RR De Krijger JJ van Dongen FJ Staal, Blood 2009 113 546 554 10.1182/blood-2008-06-163774 18832654
43. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. T Reya M O'Riordan R Okamura E Devaney K Willert R Nusse R Grosschedl, Immunity 2000 13 15 24 10.1016/S1074-7613(00)00004-2 10933391
44. Constitutively active beta-catenin promotes expansion of multipotent hematopoietic progenitors in culture. Y Baba T Yokota H Spits KP Garrett S Hayashi PW Kincade, J. Immunol 2006 177 2294 2303 16887990
45. Frizzled 9 knock-out mice have abnormal B-cell development. Erik A Ranheim Helen CK Kwan Tannishtha Reya Yu-Ker Wang Irving L Weissman Uta Francke, Blood 2005 105 2487 2494 10.1182/blood-2004-06-2334 15572594
46. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. FJ Staal J Meeldijk P Moerer P Jay BC van de Weerdt S Vainio GP Nolan H Clevers, Eur J Immunol 2001 31 285 293 10.1002/1521- 4141(200101)31:1<285::AID-IMMU2853.0.CO;2-D 11265645
47. Wnt signaling arrests effector T cell differentiation and generates CD8+memory stem cells. L Gattinoni XS Zhong DC Palmer Y Ji CS Hinrichs Z Yu C Wrzesinski A Boni L Cassard LM Garvin CM Paulos P Muranski NP Restifo, Nat Med 2009 15 808 813 10.1038/nm.1982 19525962
48. Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. Y Baba KP Garrett PW Kincade, Immunity 2005 23 599 609 10.1016/j.immuni.2005.10.009 16356858
49. Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. F Weerkamp JJ van Dongen FJ Staal, Leukemia 2006 20 1197 1205 10.1038/sj.leu.2404255 16688226
50. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. NI Khan KF Bradstock LJ Bendall, Br J Haematol 2007 138 338 348 10.1111/j.1365-2141.2007.06667.x 17614820
51. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. A Valencia J Romn-Gámez J Cervera E Such E Barragn P Bolufer F Moscardá GF Sanz MA Sanz, Leukemia 2009 23 1658 1666 10.1038/leu.2009.86 19387464
52. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. E Jost J Schmid S Wilop C Schubert H Suzuki JG Herman R Osieka O Galm, Br J Haematol 2008 142 745 753 10.1111/j.1365-2141.2008.07242.x 18537968
53. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. KS Minke P Staib A Puetter I Gehrke RK Gandhirajan A Schlösser EK Schmitt M Hallek KA Kreuzer, Eur J Haematol 2009 82 165 175 10.1111/j.1600-0609.2008.01188.x 19067737
54. Beta-catenin mutations are not observed in chronic myeloid leukemia. Z Sercan M Pehlivan D Gokturk HO Sercan, Tumori 2009 95 836 839 20210255
55. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. D Lu Y Zhao R Tawatao HB Cottam M Sen LM Leoni TJ Kipps M Corr DA Carson, PNAS 2004 101 3118 3123 10.1073/pnas.0308648100 14973184
56. Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia. QL Wu C Zierold EA Ranheim, Blood 2009 113 3031 3039 10.1182/blood-2008-06-163303 19179304
57. Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells. DN Everly Jr S Kusano N Raab-Traub, J Virol 2004 78 11648 11655 10.1128/JVI.78.21.11648-11655.2004 15479806
58. Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression. J Dutta-Simmons Y Zhang G Gorgun M Gatt M Mani T Hideshima K Takada NE Carlson DE Carrasco YT Tai N Raje AG Letai KC Anderson DR Carrasco, Blood 2009 114 2699 2708 19652203
59. beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model. E Ashihara E Kawata Y Nakagawa C Shimazaski J Kuroda K Taniguchi H Uchiyama R Tanaka A Yokota M Takeuchi Y Kamitsuji T Inaba M Taniwaki S Kimura T Maekawa, Clin Cancer Res 2009 15 2731 2738 10.1158/1078-0432.CCR-08-1350 19351774
60. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. P Gelebart M Anand H Armanious AC Peters J Dien Bard HM Amin R Lai, Blood 2008 112 5171 5179 10.1182/blood-2008-02-139212 18787224
61. Biological and clinical significance of GSK-3beta in mantle cell lymphoma - an immunohistochemical study. R Chung AC Peters H Armanious M Anand P Gelebart R Lai, Int J Clin Exp Pathol 2010 3 244 253 20224723
62. Frequent b-catenin overexpression without exon 3 mutation in cutaneous lymphomas. Barbara Bellei Alberto Pacchiarotti Marie Perez Tullio Faraggiana, Modern Pathology 2004 17 1275 1281 10.1038/modpathol.3800181 15195109
63. Abnormal Wnt signaling and stem cell activation in reactive lymphoid tissue and low-grade marginal zone lymphoma. D Zhang MF O'neil MT Cunningham F Fan M Olyaee L Li, Leuk Lymphoma 2010 51 906 910 10.3109/10428191003695645 20233054
64. Targeting Wnt pathway in lymphoma and myeloma cells. Matthias Schmidt Elisabeth Sievers Tomoyuki Endo Lu Desheng Dennis Carson Ingo GH Schmidt-Wolf, British Journal of Haematology 2008 144 796 798 10.1111/j.1365-2141.2008.07503.x 19036118
65. Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. T Kawahara N Kawaguchi-Ihara Y Okuhashi M Itoh N Nara S Tohda, Anticancer Res 2009 29 4629 4632 20032413